| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.1 | 0.7 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |